Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

The RSV vaccination eligibility age has been lowered from 60 years to 50 years according to an update on the CDC website.

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.

Salarius also announces continued progress in its planned merger with Decoy Therapeutics Inc. (Decoy). Under the definitive agreement announced on January 13, 2025, Decoy will merge with a wholly ...

During the monsoon season, raw ginger water emerges as a natural remedy to combat respiratory issues. Its anti-inflammatory ...

What you need to knowNB.1.8.1. — also called \"Nimbus” — is a subvariant of the dominant Omicron variant of SARS-CoV-2.It has ...

Test positivity for common cold coronaviruses significantly declined following widespread SARS-CoV-2 infection and COVID-19 ...

Adults as young as 50 may now qualify for an RSV vaccine if they have certain health conditions, according to a quiet update ...

Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

For Nick, watching his eight-year-old daughter perform onstage to over a hundred people, including Aussie actors, felt like a ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...

India has over 2,500 political parties — Prime Minister Modi shocks Ghana's Parl ...